Author

Shaojun Wang

Observed names: S. Wang, Shu‐Huai Wang

Institutions: Yan'an University, Inner Mongolia Medical University

Observed institutions: China Medical University, Yan'an University, 3D Medicines, Inc. (China), Inner Mongolia Medical University

ORCID: 0009-0003-8651-3914

Observed ORCID: 0009-0003-8651-3914

OpenAlex ID: A5001451758

Down‐regulation of β‐catenin and the associated migration ability by Taiwanin C in arecoline and 4‐NQO‐induced oral cancer cells via GSK‐3β activation

2016 · Cheng‐Hong Hsieh, Hsi‐Hsien Hsu, et al. · Molecular Carcinogenesis · 29

A Three-agent Regimen for Triple Negative Breast Cancer Treatment

2025 · Shaojun Wang, Congxiu Huang, et al. · Recent Patents on Anti-Cancer Drug Discovery · 2

Retraction: Tocilizumab inhibits neuronal cell apoptosis and activates STAT3 in cerebral infarction rat model

2025 · Shaojun Wang, Jun Zhou, et al. · Biomolecules and Biomedicine

599P Tumor mutation burden is a predictive biomarker for survival to patients with ovarian carcinoma

2022 · N. Liu, C. Huang, et al. · Annals of Oncology

Works count: 4

Citation count: 31

H-index: 2

I10-index: 1